Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1201256

Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues


Debeljak, Željko; Vinković Vrček, Ivana; Drinković, Nikša; Micek, Vedran, Galić, Emerik, Gorup, Dunja; Ćurlin, Marija; Mandić, Dario; Bandjak, Ana; Pem, Barbara; Kalčec, Nikolina; Ilić, Krunoslav et al.
Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues // Analyst, 147 (2022), 3201-3208 doi:10.1039/D2AN00355D (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1201256 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues
(Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues)

Autori
Debeljak, Željko ; Vinković Vrček, Ivana ; Drinković, Nikša ; Micek, Vedran, Galić, Emerik, Gorup, Dunja ; Ćurlin, Marija ; Mandić, Dario ; Bandjak, Ana ; Pem, Barbara ; Kalčec, Nikolina ; Ilić, Krunoslav ; Pavičić, Ivan ; Mimica, Suzana ; Günday-Türeli ; Nazende ; Türeli, Emre

Izvornik
Analyst (0003-2654) 147 (2022); 3201-3208

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
mass spectrometry ; imaging ; doxorubicin ; nanoformulation

Sažetak
Administration of cytotoxic agents like doxorubicin (DOX) is restrained by the effects on different non-targeted/non-cancerous tissues, which instigates the development of nano-enabled drug delivery systems, among others. In this study, imaging mass spectrometry (IMS) was selected to examine the effects of DOX nanoformulations on non-targeted tissues. Chemical alterations induced by liposomal (LPS) and poly (lactic-co-glycolic acid) (PLG) nanoformulations were assessed against the ones induced by the conventional (CNV) formulation. Kidney cryosections of the treated and control Wistar rats were used as a model of the non-targeted tissue and analyzed by MALDI TOF IMS in the 200- 1000 Da m/z range. Principal component analysis (PCA) and Volcano plots of the average mass spectra demonstrated a large overlap between treatments. However, the Venn diagram of significant m/z values revealed a nanoformulation- specific fingerprint consisting of 59 m/z values, which set them apart from the CNV formulation characterized by the fingerprint of 22 significant m/z values. Fingerprint m/z values that were putatively annotated by metabolome database search were linked to apoptosis, cell migration and proliferation. In CNV and PLG cases, false discovery rate adjusted ANOVA showed no differences in the spatial distribution of fingerprint m/z values between the histological substructures like glomeruli and convoluted tubules indicating their tissue-nonselective effect. LPS caused the least significant changes in m/z values and some of the LPS-specific fingerprint m/z values were primarily distributed in the glomeruli. The IMS based procedure successfully differentiated the effects of DOX formulations on the model non-targeted tissue, thus indicating the importance of IMS in effective drug development.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija



POVEZANOST RADA


Projekti:
EK-H2020-953110 - Farmaceutski otvorena ispitna platforma za nano-farmaceutske inovativne proizvode (Phoenix) (Vinković Vrček, Ivana, EK ) ( CroRIS)
HRZZ-PZS-2019-02-4323 - Siguran pristup za razvoj nano-sustava za ciljanu isporuku lijekova u mozak (SENDER) (Vinković Vrček, Ivana, HRZZ ) ( CroRIS)

Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Fakultet agrobiotehničkih znanosti Osijek,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Hrvatsko katoličko sveučilište, Zagreb

Poveznice na cjeloviti tekst rada:

doi pubs.rsc.org

Citiraj ovu publikaciju:

Debeljak, Željko; Vinković Vrček, Ivana; Drinković, Nikša; Micek, Vedran, Galić, Emerik, Gorup, Dunja; Ćurlin, Marija; Mandić, Dario; Bandjak, Ana; Pem, Barbara; Kalčec, Nikolina; Ilić, Krunoslav et al.
Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues // Analyst, 147 (2022), 3201-3208 doi:10.1039/D2AN00355D (međunarodna recenzija, članak, znanstveni)
Debeljak, Ž., Vinković Vrček, I., Drinković, N., Micek, Vedran, Galić, Emerik, Gorup, Dunja, Ćurlin, M., Mandić, D., Bandjak, A., Pem, B., Kalčec, N. & Ilić, K. (2022) Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues. Analyst, 147, 3201-3208 doi:10.1039/D2AN00355D.
@article{article, author = {Debeljak, \v{Z}eljko and Vinkovi\'{c} Vr\v{c}ek, Ivana and Drinkovi\'{c}, Nik\v{s}a and \'{C}urlin, Marija and Mandi\'{c}, Dario and Bandjak, Ana and Pem, Barbara and Kal\v{c}ec, Nikolina and Ili\'{c}, Krunoslav and Pavi\v{c}i\'{c}, Ivan and Mimica, Suzana and T\"{u}reli, Emre}, year = {2022}, pages = {3201-3208}, DOI = {10.1039/D2AN00355D}, keywords = {mass spectrometry, imaging, doxorubicin, nanoformulation}, journal = {Analyst}, doi = {10.1039/D2AN00355D}, volume = {147}, issn = {0003-2654}, title = {Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues}, keyword = {mass spectrometry, imaging, doxorubicin, nanoformulation} }
@article{article, author = {Debeljak, \v{Z}eljko and Vinkovi\'{c} Vr\v{c}ek, Ivana and Drinkovi\'{c}, Nik\v{s}a and \'{C}urlin, Marija and Mandi\'{c}, Dario and Bandjak, Ana and Pem, Barbara and Kal\v{c}ec, Nikolina and Ili\'{c}, Krunoslav and Pavi\v{c}i\'{c}, Ivan and Mimica, Suzana and T\"{u}reli, Emre}, year = {2022}, pages = {3201-3208}, DOI = {10.1039/D2AN00355D}, keywords = {mass spectrometry, imaging, doxorubicin, nanoformulation}, journal = {Analyst}, doi = {10.1039/D2AN00355D}, volume = {147}, issn = {0003-2654}, title = {Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues}, keyword = {mass spectrometry, imaging, doxorubicin, nanoformulation} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font